Two New Breast Cancer Drugs Show Promise In Early Trials

Women with HER2-positive breast cancer may soon have some brand new treatment options after two experimental drugs performed well in clinical trials.

Read the full post on Forbes - Healthcare

Victoria Forster, Contributor